Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Akriti Singh
Institution:
KPC Medical College and Hospital
Observed institution:
KPC Medical College and Hospital
ORCID:
0009-0002-5784-5058
Observed ORCID:
0009-0002-5784-5058
OpenAlex ID:
A5024208405
Comparative efficacy and safety of semaglutide 2.4 mg and tirzepatide 5–15 mg in obesity with or without type 2 diabetes: A systematic review of Phase 3 clinical trials
2025
·
Akriti Singh
, Awadhesh Kumar Singh
, et al.
·
Diabetes & Metabolic Syndrome Clinical Research & Reviews
·
16
Diet in Thyroid Disorders: A Survey among Clinicians and a Review of the Current Perspective
2024
·
Awadhesh Kumar Singh
, Subhankar Chatterjee
, et al.
·
Indian Journal of Endocrinology and Metabolism
·
5
Inadvertent glucagon-like peptide-1 receptor agonist exposure in pregnancy: reassuring data, unresolved safety (letter to the editor)
2026
·
Ritu Singh
, Akriti Singh
, et al.
·
American Journal of Obstetrics and Gynecology
·
1
Short‐Term HbA1c Non‐Inferiority of Synthetic Semaglutide Should Not Be Conflated With Full Therapeutic Interchangeability
2026
·
Awadhesh Kumar Singh
, Akriti Singh
, et al.
·
Diabetes Obesity and Metabolism
·
1
Human pregnancy outcomes after early glucagon-like peptide-1 receptor agonist exposure: A scoping review
2026
·
Ritu Singh
, Akriti Singh
, et al.
·
World Journal of Diabetes
PDF
Synthetic Versus Reference Semaglutide for Weight Management: Reporting Gaps and Clinical Claims
2026
·
Awadhesh Kumar Singh
, Akriti Singh
, et al.
·
Diabetes Obesity and Metabolism
Author response for "Synthetic versus Reference Semaglutide for Weight Management: Reporting Gaps and Clinical Claims"
2026
·
Awadhesh Kumar Singh
, Akriti Singh
, et al.
·
Publons reviews and discussion
Periconceptional GLP-1 Receptor Agonist Exposure
2026
·
Ritu Singh
, Akriti Singh
, et al.
·
JACC Advances
PDF
Author response for "Synthetic versus Reference Semaglutide for Weight Management: Reporting Gaps and Clinical Claims"
2026
·
Awadhesh Kumar Singh
, Akriti Singh
, et al.
·
Publons reviews and discussion
Strengths and Limitations of Synthetic Versus Reference Semaglutide in Indian Adults With Type 2 Diabetes and Obesity: A Systematic Critical Appraisal of the Published Phase III Evidence
2026
·
Awadhesh Kumar Singh
, Akriti Singh
, et al.
Author response for "Short-term HbA1c non-inferiority of synthetic semaglutide should not be conflated with full therapeutic interchangeability"
2026
·
Awadhesh Kumar Singh
, Akriti Singh
, et al.
·
Publons reviews and discussion
Four Faces of Male Hypogonadism: a Case Series of Diverse Etiologies
2026
·
Dipra dattasarma
, Nirmalya Roy
, et al.
·
SSRN Electronic Journal
Tirzepatide: Responders vs. Non-Responders
2025
·
Akriti Singh
, Awadhesh Kumar Singh
·
Clinical Diabetology
PDF
Show more works
View as search
Works count:
13
Citation count:
23
H-index:
2
I10-index:
1
Year
Topic
Type